AT
MRNA icon

Avalon Trust’s Moderna MRNA Stock Holding History

Avalon Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-314
Closed -$8.11K – 565
2025
Q3 		$8.11K Buy
+314
New +$8.76K ﹤0.01% 422
2023
Q4 		– Sell
-2,326
Closed -$240K – 356
2023
Q3 		$240K Hold
2,326
– – 0.02% 108
2023
Q2 		$283K Hold
2,326
– – 0.03% 106
2023
Q1 		$357K Buy
+2,326
New +$384K 0.04% 96

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Avalon Trust's MRNA Position: Q4 2025 in Review

Avalon Trust sold out of Moderna (MRNA) in Q4 2025, closing a stake of 314 shares — an estimated $8.11K sold.

Avalon Trust first reported a position in MRNA in Q1 2023 and held it in 4 quarters. The position peaked at $357K in Q1 2023. 673 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Avalon Trust reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • Avalon Trust sold 314 Moderna shares in Q4 2025, an estimated $8.11K.
  • Avalon Trust first reported a position in Moderna in Q1 2023 and held it in 4 quarters.
  • Avalon Trust's Moderna position peaked at $357K in Q1 2023.
  • 673 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Avalon Trust's 13F filing for Q4 2025, filed 9 Feb 2026.